Mark Lawler headshot

Mark Lawler, Prof.

Associate Pro-Vice-Chancellor, Professor of Digital Health, and Chair in Translational Cancer Genomics

Queen's University Belfast (QUB)

Mark is an internationally renowned scientist with over 200 papers including key publications in the highest impact journals. His work has been recognised by numerous national and international awards. He is Associate Director of Health Data Research Wales-Northern Ireland and Scientific Director of DATA-CAN, the UK’s National Health Data Research Hub for Cancer.

Mark has a strong commitment to patient-centred research/care and to addressing cancer inequalities. He was architect of the European Cancer Patient’s Bill of Rights, launched in the European Parliament on World Cancer Day 2014. The Bill of Rights received the 2018 European Health Award, a prestigious award for partnerships that yield real health impact in Europe.  Mark’s work on addressing inequalities formed the centrepiece in the development by the European Cancer Organisation (E.C.O) of the European Code of Cancer Practice, launched (virtually) with EU Health and Food Safety Commissioner Stella Kyriakides in Brussels (September 2020).

Mark’s work on Covid-19 and its impact on cancer services and cancer patients has received international attention. He co-chairs E.C.O’s Special Focussed Network on  Covid-19 and cancer, which launched its 7-Point plan to Build Back Smarter from Covid. He presented recent data on Covid’s impact on cancer in Europe to the Europe Beating Cancer Committee in the European Parliament and launched E.C.O’s pan European Time To Act Campaign to ensure that Covid-19 does not stop us from tackling cancer.  This work recently received the prestigious Royal College of Physicians Excellence in Patient Care Award.

Mark recently received the Irish Association for Cancer Research’s Outstanding Contribution to cancer research award, for his pioneering work on cancer research and cancer care on the island of Ireland. Mark is Chair of the International Cancer Benchmarking Partnership, an international collaborative employing data- driven approaches to improve outcomes for cancer patients.

Advertizing
Advertizing

Other speakers in 2021

Bulgaria

Deyan Denev

Director
Association of Research-based Pharmaceutical Manufacturers Bulgaria (ARPHARM Bulgaria)
Menu
Skip to content